Fatty Acid Supplementation in Children With ASD (Study 2)
Status:
Not yet recruiting
Trial end date:
2024-01-31
Target enrollment:
Participant gender:
Summary
The objective of the protocol is to test the impact of Omega 3-6 on pre-specified biological
signatures (IL-1β, IL-2, and IFNγ) and to correlate changes in the biological signatures with
changes in ASD symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
Sarah Keim
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)